Aquestive Therapeutics, Inc. — Director's Dealing 2021

Jun 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-06-15

Reporting Person: Taglietti Marco (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-15	Stock Option (Right to Purchase)	$4.04	A	20000	Acquired	2031-06-15	Common Stock (20000)	Direct

Footnotes

F1: The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.